Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 group M subtypes, intersubtype recombinants and unclassified (U) variants. The viral diversity outside the major metropolitan regions (Luanda and Cabinda) and the prevalence of transmitted drug resistance mutations (DRM) since the introduction of HAART in 2004, however, has been barely studied. gene and their drug resistance profile was analyzed. = 0.0012) regions. DRM to NRTI and/or NNRTI were detected in 16.3% of patients analyzed.These results demonstrate a heterogeneous distribution of HIV-1 genetic variants across different regions in Angola and also revealed an unexpected high frequency of DRM to RT inhibitors in patients that have repor...
Abstract Background Despite the advances in therapy, the occurrence of drug-resistant human immunode...
The development of resistance mutations in drug-targeted HIV-1 genes compromises the success of anti...
In this study, we investigated the prevalence of human immunodeficiency virus type 1 (HIV-1) drug re...
Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 g...
HIV-1 genetic diversity and drug resistance mutations (DRMs) remain a public health concern mainly i...
To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resistance (TDR)...
Objectives To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resi...
Project Pró-África CNPq n˚ 440145/2015-5Monitoring genetic diversity and drug resistance mutations (...
Monitoring genetic diversity and drug resistance mutations (DRMs) is critical for understanding HIV ...
Angola has an extremely diverse HIV-1 epidemic fueled in part by the frequent interchange of people ...
The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is known abo...
The remarkable viral diversity remains a big challenge to the development of HIV vaccines and optima...
<div><p>The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is k...
The remarkable viral diversity remains a big challenge to the development of HIV vaccines and optima...
<p>a) Frequency of “pure” subtypes, inter-subtype recombinants and unclassified (U) sequences within...
Abstract Background Despite the advances in therapy, the occurrence of drug-resistant human immunode...
The development of resistance mutations in drug-targeted HIV-1 genes compromises the success of anti...
In this study, we investigated the prevalence of human immunodeficiency virus type 1 (HIV-1) drug re...
Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 g...
HIV-1 genetic diversity and drug resistance mutations (DRMs) remain a public health concern mainly i...
To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resistance (TDR)...
Objectives To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resi...
Project Pró-África CNPq n˚ 440145/2015-5Monitoring genetic diversity and drug resistance mutations (...
Monitoring genetic diversity and drug resistance mutations (DRMs) is critical for understanding HIV ...
Angola has an extremely diverse HIV-1 epidemic fueled in part by the frequent interchange of people ...
The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is known abo...
The remarkable viral diversity remains a big challenge to the development of HIV vaccines and optima...
<div><p>The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is k...
The remarkable viral diversity remains a big challenge to the development of HIV vaccines and optima...
<p>a) Frequency of “pure” subtypes, inter-subtype recombinants and unclassified (U) sequences within...
Abstract Background Despite the advances in therapy, the occurrence of drug-resistant human immunode...
The development of resistance mutations in drug-targeted HIV-1 genes compromises the success of anti...
In this study, we investigated the prevalence of human immunodeficiency virus type 1 (HIV-1) drug re...